» Articles » PMID: 36618567

An Excursion into Ocular Tuberculosis

Overview
Specialty Ophthalmology
Date 2023 Jan 9
PMID 36618567
Authors
Affiliations
Soon will be listed here.
Abstract

Till today, ocular tuberculosis (OTB) presents clinicians with significant challenges in diagnosis and management. There is no one-size-fits-all approach to a heterogeneous disease like OTB, and clinicians often have to consider a multitude of factors when initiating treatment, such as tuberculosis endemicity, the probability of a true OTB diagnosis in the setting of nonspecific ocular features, the effective duration of treatment, and the likelihood of vision-threatening complications in the patient. It is no wonder that treatment protocols are widely varied globally. There have been recent developments in the standardization of nomenclature and therapeutic strategies for OTB, as established by the Collaborative OTB Study Working Group. In this review, we referred to findings in retrospective studies, international clinical guidelines, and OTB consortiums, to explore the clinical presentations, investigations, and updated management principles for patients with presumed tubercular uveitis.

Citing Articles

Kaleidoscope of ocular tuberculosis.

Sharma M, Arora A, Gupta V Eye (Lond). 2025; .

PMID: 40044839 DOI: 10.1038/s41433-025-03740-2.


An update on immunological and molecular tests and their impact in infectious uveitis.

Thomas J, Nguyen N, Fashina T, Huang Y, Yeh S, Conrady C Front Ophthalmol (Lausanne). 2024; 3:1132131.

PMID: 38983089 PMC: 11182284. DOI: 10.3389/fopht.2023.1132131.


Developments in uveitis.

Tugal-Tutkun I Saudi J Ophthalmol. 2023; 36(4):335-336.

PMID: 36618571 PMC: 9811931. DOI: 10.4103/sjopt.sjopt_211_22.

References
1.
Agrawal R, Gunasekeran D, Agarwal A, Carreno E, Aggarwal K, Gupta B . The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis. Ocul Immunol Inflamm. 2018; 28(sup1):38-48. DOI: 10.1080/09273948.2018.1489061. View

2.
Kazokoglu H, Onal S, Tugal-Tutkun I, Mirza E, Akova Y, Ozyazgan Y . Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008; 15(5):285-93. DOI: 10.1080/09286580802262821. View

3.
Teixeira-Lopes F, Alfarroba S, Dinis A, Gomes M, Tavares A . Ocular tuberculosis - A closer look to an increasing reality. Pulmonology. 2018; 24(5):289-293. DOI: 10.1016/j.pulmoe.2018.02.006. View

4.
Gunasekeran D, Gupta B, Cardoso J, Pavesio C, Agrawal R . Visual Morbidity and Ocular Complications in Presumed Intraocular Tuberculosis: An Analysis of 354 Cases from a Non-Endemic Population. Ocul Immunol Inflamm. 2017; 26(6):865-869. DOI: 10.1080/09273948.2017.1296580. View

5.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A . Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis. Ophthalmology. 2020; 128(2):277-287. DOI: 10.1016/j.ophtha.2020.06.052. View